Found 19 matching trials
Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia
PHASE3This is a Phase 3, randomized, blinded, and placebo-controlled clinical tri...
Location
Multiple Locations
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
PHASE1Background:
Immunotherapy drugs help the body to fight cancer. Scientists ...
Location
National Institutes of Health Clinical Center
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
EARLY_PHASE1This early phase I trial tests the safety and how well N-803 works in treat...
Location
Northwestern University
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
PHASE2This study consists of 2 portions. The phase 2 portion is an open-label, si...
Status
Active Not Recruiting
Location
Chan Soon-Shiong Institute for Medicine (CSSIFM)
NAI for Sepsis With Persistent Lymphopenia
PHASE2This is a Phase 2, randomized, open-label study evaluating the safety and e...
Location
Multiple Locations
Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS)
PHASE2This Phase 2 study tests whether adding two immune therapies - nogapendekin...
Location
Multiple Locations
A Study to Assess Anktiva in Patients With Long Covid-19.
PHASE2This study will test the safety and tolerability of Anktiva in patients wit...
Location
University of California - San Francisco
A Study to Examine Anktiva for the Treatment of COVID-19.
PHASE2This study will examine the safety and effectiveness of Anktiva in treating...
Location
Chan Soon-Schiong Institute for Medicine (CSSIFM)
First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
PHASE1This is a single center, phase Ib/II study combining an anti-PD-1 antibody ...
Location
Washington University School of Medicine
PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
PHASE2The purpose of this research study is to test the safety and efficacy of th...
Location
Brigham and Women's Hospital